Avella

Jun 28, 2018

Avella Selected by Array BioPharma Inc. to distribute BRAFTOVI(TM) (encorafenib) and MEKTOVI® (binimetinib)

Apr 27, 2018

Avella Selected by Otsuka to distribute JYNARQUE

Apr 26, 2018

Avella Releases New Report on Anticipated Specialty Medication Approvals

Apr 24, 2018

Avella to improve access to naloxone, an opioid overdose-reversing medication, through an innovative new program

Oct 18, 2017

Avella launches NurseConnect program to engage and support patients

Aug 31, 2017

Avella launches Pain and Addiction Management Mobile App for physicians

Aug 16, 2017

Avella Specialty Pharmacy again named one of Inc. 5000's Fastest Growing Companies

Aug 09, 2017

Avella Launches New e-Commerce Platform for Ophthalmology Providers

Jun 15, 2017

Advanced Pharma, Inc. d/b/a Avella of Houston Issues Voluntary Nationwide Recall of All Unexpired NitroGlycerin Injection in 5% Dextrose USP Products Produced at its Houston Location from March 3, 2017 through May 31, 2017 Due to Sub-Potency